DE69635269D1 - Neue staphylokinase derivate - Google Patents

Neue staphylokinase derivate

Info

Publication number
DE69635269D1
DE69635269D1 DE69635269T DE69635269T DE69635269D1 DE 69635269 D1 DE69635269 D1 DE 69635269D1 DE 69635269 T DE69635269 T DE 69635269T DE 69635269 T DE69635269 T DE 69635269T DE 69635269 D1 DE69635269 D1 DE 69635269D1
Authority
DE
Germany
Prior art keywords
dna fragment
directed mutagenesis
plasmid
host cell
staphylokinase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69635269T
Other languages
English (en)
Other versions
DE69635269T2 (de
Inventor
Desire Jose Collen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP95200023A external-priority patent/EP0721982A1/de
Priority claimed from EP95201531A external-priority patent/EP0721013B1/de
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Publication of DE69635269D1 publication Critical patent/DE69635269D1/de
Application granted granted Critical
Publication of DE69635269T2 publication Critical patent/DE69635269T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69635269T 1995-01-06 1996-01-03 Neue staphylokinase derivate Expired - Fee Related DE69635269T2 (de)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
EP95200023A EP0721982A1 (de) 1995-01-06 1995-01-06 Neue staphylokinase Derivative
US08/371,505 US5695754A (en) 1995-01-06 1995-01-11 Staphylokinase derivatives
EP95201531A EP0721013B1 (de) 1995-01-06 1995-06-09 Neue staphylokinase Derivate
US49909295A 1995-07-06 1995-07-06
JP7299781A JPH08289790A (ja) 1995-01-06 1995-11-17 新規なスタフィロキナーゼ誘導体
PCT/EP1996/000081 WO1996021016A2 (en) 1995-01-06 1996-01-03 New staphylokinase derivatives

Publications (2)

Publication Number Publication Date
DE69635269D1 true DE69635269D1 (de) 2006-02-23
DE69635269T2 DE69635269T2 (de) 2006-06-14

Family

ID=27514236

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69635269T Expired - Fee Related DE69635269T2 (de) 1995-01-06 1996-01-03 Neue staphylokinase derivate

Country Status (22)

Country Link
EP (1) EP0793723B1 (de)
JP (1) JPH08289790A (de)
CN (1) CN1154729C (de)
AT (1) ATE306550T1 (de)
AU (1) AU705119B2 (de)
BG (1) BG64344B1 (de)
BR (1) BR9606724A (de)
CA (1) CA2206479A1 (de)
CZ (1) CZ290685B6 (de)
DE (1) DE69635269T2 (de)
EA (1) EA000121B1 (de)
EE (1) EE9700150A (de)
ES (1) ES2248805T3 (de)
FI (1) FI972862A (de)
HU (1) HUP9802915A3 (de)
NO (1) NO973083L (de)
NZ (1) NZ298801A (de)
PL (1) PL184348B1 (de)
RO (1) RO116969B1 (de)
SK (1) SK89297A3 (de)
TR (1) TR199700600T1 (de)
WO (1) WO1996021016A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5951980A (en) * 1995-01-06 1999-09-14 Leuven Research & Development Vzw Identification, production and use of new staphylokinase derivatives with reduced immunogenicity
JP2003500003A (ja) * 1998-10-30 2003-01-07 ノボザイムス アクティーゼルスカブ 低いアレルゲン性のタンパク質変異型
US6686164B1 (en) 1998-10-30 2004-02-03 Novozymes A/S Low allergenic protein variants
CN100342007C (zh) * 2000-01-28 2007-10-10 复旦大学 一种新型重组葡激酶及其制备方法
US6673580B2 (en) 2000-10-27 2004-01-06 Genentech, Inc. Identification and modification of immunodominant epitopes in polypeptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0621899B1 (de) * 1991-12-30 1996-06-19 Medac Gesellschaft für klinische Spezialpräparate mbH Expression signalpeptid-freier staphylokinasen

Also Published As

Publication number Publication date
EP0793723A2 (de) 1997-09-10
EP0793723B1 (de) 2005-10-12
BG101556A (en) 1998-02-27
AU705119B2 (en) 1999-05-13
RO116969B1 (ro) 2001-08-30
BG64344B1 (bg) 2004-10-29
CN1168156A (zh) 1997-12-17
WO1996021016A2 (en) 1996-07-11
HUP9802915A3 (en) 2001-02-28
EA199700073A1 (ru) 1997-12-30
FI972862A (fi) 1997-09-03
ATE306550T1 (de) 2005-10-15
PL184348B1 (pl) 2002-10-31
MX9705041A (es) 1998-07-31
JPH08289790A (ja) 1996-11-05
BR9606724A (pt) 1998-01-13
CN1154729C (zh) 2004-06-23
NO973083L (no) 1997-08-04
NZ298801A (en) 2000-01-28
SK89297A3 (en) 1998-05-06
PL321181A1 (en) 1997-11-24
DE69635269T2 (de) 2006-06-14
HUP9802915A2 (hu) 1999-03-29
EE9700150A (et) 1997-12-15
CA2206479A1 (en) 1996-07-11
AU4437796A (en) 1996-07-24
CZ290685B6 (cs) 2002-09-11
FI972862A0 (fi) 1997-07-04
TR199700600T1 (xx) 1998-01-21
WO1996021016A3 (en) 1996-09-12
EA000121B1 (ru) 1998-08-27
CZ210497A3 (en) 1997-11-12
NO973083D0 (no) 1997-07-02
ES2248805T3 (es) 2006-03-16

Similar Documents

Publication Publication Date Title
US5100784A (en) Process for the preparation of mature human serum albumin
US5496924A (en) Fusion protein comprising an interleukin-2 fragment ballast portion
DE69822251T2 (de) Verfahren zur Herstellung von mikrobieller Transglutaminase
IE863334L (en) Fusion proteins with a eukaryotic ballast portion
Svendsen et al. The primary structure of the glutamic acid-specific protease ofStreptomyces griseus
JPH03228682A (ja) E.コリでの非融合タンパク質の調製方法
WO1999040198A3 (en) Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance
ATE306550T1 (de) Neue staphylokinase derivate
EP0528686B8 (de) Verfahren zur Herstellung von Peptiden
JP3319605B2 (ja) ストレプトミセスにおける外来タン白質の製造法
DD274053A5 (de) Verfahren zur Produktion eines menschlichen, einkettigen Plasminogenaktivators
JP2637392B2 (ja) 遺伝子操作による生物活性β−NGFの生産方法
DK173380B1 (da) Præparat med mitogenisk aktivitet over for menneskeforhuds-fibroblaster, fremgangsmåde til fremstilling af en human, basisk
EP0837694A4 (de) Membranproteine von leptospira
EP0352387B1 (de) Verfahren zur Herstellung von Hirudin
DE3900770A1 (de) Verfahren zur herstellung von pdgf-a und pdgf-aa
WO2000061727A2 (de) Herstellung von pankreatischer procarboxypeptidase b, isoformen und muteinen davon und ihre verwendung
RU2143492C1 (ru) Рекомбинантная плазмида, кодирующая гибридный белок - предшественник инсулина человека (варианты), штамм бактерий e.coli - продуцент гибридного белка - предшественника инсулина человека (варианты), способ получения инсулина человека
Ribó et al. Production of Human Pancreatic Ribonuclease inSaccharomyces cerevisiaeandEscherichia coli
IE902832A1 (en) Dna fragment containing at least one protease gene, a¹cloning vector containing such a dna fragment, a host cell¹transformed with a cloning vector constructed in this¹manner, and also the proteases produced by, or products such¹as foodstuffs prepared with, such host cells
JPS61282080A (ja) 新規なシグナルアミノ酸配列をコ−ドするdnaを有するプラスミド
WO1992002626A1 (en) Eliminating internal initiation of soluble cd4 gene
JPH09168391A (ja) 排出機能を有するフラジェリンのn端側アミノ酸断片の用途
JPH02219570A (ja) ヒト5―リポキシゲナーゼの製造方法
JPH0394681A (ja) 改良されたdnaの製法及び該dnaを使用する蛋白質又はペプチドの製法

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee